288 related articles for article (PubMed ID: 21911026)
1. The factor H-binding fragment of PspC as a vaccine antigen for the induction of protective humoral immunity against experimental pneumococcal sepsis.
Ricci S; Janulczyk R; Gerlini A; Braione V; Colomba L; Iannelli F; Chiavolini D; Oggioni MR; Björck L; Pozzi G
Vaccine; 2011 Oct; 29(46):8241-9. PubMed ID: 21911026
[TBL] [Abstract][Full Text] [Related]
2. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection.
Hanniffy SB; Carter AT; Hitchin E; Wells JM
J Infect Dis; 2007 Jan; 195(2):185-93. PubMed ID: 17191163
[TBL] [Abstract][Full Text] [Related]
3. The proline-rich region of pneumococcal surface proteins A and C contains surface-accessible epitopes common to all pneumococci and elicits antibody-mediated protection against sepsis.
Daniels CC; Coan P; King J; Hale J; Benton KA; Briles DE; Hollingshead SK
Infect Immun; 2010 May; 78(5):2163-72. PubMed ID: 20194601
[TBL] [Abstract][Full Text] [Related]
4. Enhanced protective immunity against pneumococcal infection with PspA DNA and protein.
Moore QC; Bosarge JR; Quin LR; McDaniel LS
Vaccine; 2006 Jul; 24(29-30):5755-61. PubMed ID: 16759765
[TBL] [Abstract][Full Text] [Related]
5. Optimized immune response elicited by a DNA vaccine expressing pneumococcal surface protein a is characterized by a balanced immunoglobulin G1 (IgG1)/IgG2a ratio and proinflammatory cytokine production.
Ferreira DM; Darrieux M; Oliveira ML; Leite LC; Miyaji EN
Clin Vaccine Immunol; 2008 Mar; 15(3):499-505. PubMed ID: 18184825
[TBL] [Abstract][Full Text] [Related]
6. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP.
Cao J; Chen D; Xu W; Chen T; Xu S; Luo J; Zhao Q; Liu B; Wang D; Zhang X; Shan Y; Yin Y
Vaccine; 2007 Jun; 25(27):4996-5005. PubMed ID: 17524530
[TBL] [Abstract][Full Text] [Related]
7. Selection of family 1 PspA molecules capable of inducing broad-ranging cross-reactivity by complement deposition and opsonophagocytosis by murine peritoneal cells.
Goulart C; Darrieux M; Rodriguez D; Pimenta FC; Brandileone MC; de Andrade AL; Leite LC
Vaccine; 2011 Feb; 29(8):1634-42. PubMed ID: 21211592
[TBL] [Abstract][Full Text] [Related]
8. Mucosal and systemic immunization with a novel attenuated pneumococcal vaccine candidate confer serotype independent protection against Streptococcus pneumoniae in mice.
Wu K; Yao R; Wang H; Pang D; Liu Y; Xu H; Zhang S; Zhang X; Yin Y
Vaccine; 2014 Jul; 32(33):4179-88. PubMed ID: 24945468
[TBL] [Abstract][Full Text] [Related]
9. Intranasal Immunization with the Commensal
Shekhar S; Khan R; Schenck K; Petersen FC
Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30683742
[No Abstract] [Full Text] [Related]
10. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
[TBL] [Abstract][Full Text] [Related]
11. In vivo binding of complement regulator factor H by Streptococcus pneumoniae.
Quin LR; Carmicle S; Dave S; Pangburn MK; Evenhuis JP; McDaniel LS
J Infect Dis; 2005 Dec; 192(11):1996-2003. PubMed ID: 16267773
[TBL] [Abstract][Full Text] [Related]
12. Cross-reactivity of antipneumococcal surface protein C (PspC) antibodies with different strains and evaluation of inhibition of human complement factor H and secretory IgA binding via PspC.
Moreno AT; Oliveira ML; Ho PL; Vadesilho CF; Palma GM; Ferreira JM; Ferreira DM; Santos SR; Martinez MB; Miyaji EN
Clin Vaccine Immunol; 2012 Apr; 19(4):499-507. PubMed ID: 22336290
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the antibody response elicited by immunization with pneumococcal surface protein A (PspA) as recombinant protein or DNA vaccine and analysis of protection against an intranasal lethal challenge with Streptococcus pneumoniae.
Vadesilho CF; Ferreira DM; Moreno AT; Chavez-Olortegui C; Machado de Avila RA; Oliveira ML; Ho PL; Miyaji EN
Microb Pathog; 2012; 53(5-6):243-9. PubMed ID: 22981893
[TBL] [Abstract][Full Text] [Related]
14. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
[TBL] [Abstract][Full Text] [Related]
15. Multivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad Protection.
Chen A; Mann B; Gao G; Heath R; King J; Maissoneuve J; Alderson M; Tate A; Hollingshead SK; Tweten RK; Briles DE; Tuomanen EI; Paton JC
Clin Vaccine Immunol; 2015 Oct; 22(10):1079-89. PubMed ID: 26245351
[TBL] [Abstract][Full Text] [Related]
16. Protection against nasal colonization with Streptococcus pneumoniae by parenteral immunization with a DNA vaccine encoding PspA (Pneumococcal surface protein A).
Ferreira DM; Oliveira ML; Moreno AT; Ho PL; Briles DE; Miyaji EN
Microb Pathog; 2010 Jun; 48(6):205-13. PubMed ID: 20206678
[TBL] [Abstract][Full Text] [Related]
17. Mucosal vaccination with a multicomponent adenovirus-vectored vaccine protects against Streptococcus pneumoniae infection in the lung.
Arévalo MT; Xu Q; Paton JC; Hollingshead SK; Pichichero ME; Briles DE; Girgis N; Zeng M
FEMS Immunol Med Microbiol; 2009 Apr; 55(3):346-51. PubMed ID: 19291171
[TBL] [Abstract][Full Text] [Related]
18. Resistance of young mice to pneumococcal infection can be improved by oral vaccination with recombinant Lactococcus lactis.
Villena J; Medina M; Racedo S; Alvarez S
J Microbiol Immunol Infect; 2010 Feb; 43(1):1-10. PubMed ID: 20434117
[TBL] [Abstract][Full Text] [Related]
19. The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease.
Richards L; Ferreira DM; Miyaji EN; Andrew PW; Kadioglu A
Immunobiology; 2010 Apr; 215(4):251-63. PubMed ID: 20071053
[TBL] [Abstract][Full Text] [Related]
20. A Combination of Recombinant Mycobacterium bovis BCG Strains Expressing Pneumococcal Proteins Induces Cellular and Humoral Immune Responses and Protects against Pneumococcal Colonization and Sepsis.
Goulart C; Rodriguez D; Kanno AI; Converso TR; Lu YJ; Malley R; Leite LCC
Clin Vaccine Immunol; 2017 Oct; 24(10):. PubMed ID: 28768668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
